Bank of America
CRBU icon

Bank of America’s Caribou Biosciences CRBU Stock Holding History

Bank of America’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
1,410,958
+113,791
+9% +$225K ﹤0.01% 4063
2026
Q1 		$2.46M Buy
1,297,167
+303,981
+31% +$522K ﹤0.01% 3972
2025
Q4 		$1.58M Sell
993,186
-81,256
-8% -$171K ﹤0.01% 4251
2025
Q3 		$2.5M Buy
1,074,442
+265,542
+33% +$501K ﹤0.01% 4626
2025
Q2 		$1.02M Sell
808,900
-291,565
-26% -$287K ﹤0.01% 5288
2025
Q1 		$1M Sell
1,100,465
-668,828
-38% -$869K ﹤0.01% 5213
2024
Q4 		$2.81M Sell
1,769,293
-2,800,953
-61% -$5.63M ﹤0.01% 4147
2024
Q3 		$8.96M Buy
4,570,246
+407,899
+10% +$835K ﹤0.01% 3179
2024
Q2 		$6.83M Buy
4,162,347
+3,045,578
+273% +$9.73M ﹤0.01% 3321
2024
Q1 		$5.74M Sell
1,116,769
-476,367
-30% -$2.94M ﹤0.01% 3480
2023
Q4 		$9.13M Sell
1,593,136
-713,662
-31% -$3.53M ﹤0.01% 2991
2023
Q3 		$11M Sell
2,306,798
-444,692
-16% -$2.76M ﹤0.01% 2627
2023
Q2 		$11.7M Buy
2,751,490
+119,105
+5% +$535K ﹤0.01% 2556
2023
Q1 		$14M Buy
2,632,385
+788,483
+43% +$4.91M ﹤0.01% 2493
2022
Q4 		$11.6M Buy
1,843,902
+1,668,395
+951% +$14.8M ﹤0.01% 2540
2022
Q3 		$1.85M Buy
175,507
+102,361
+140% +$954K ﹤0.01% 4353
2022
Q2 		$397K Buy
73,146
+53,570
+274% +$410K ﹤0.01% 5596
2022
Q1 		$180K Sell
19,576
-70,566
-78% -$743K ﹤0.01% 6533
2021
Q4 		$1.36M Buy
90,142
+55,767
+162% +$1.08M ﹤0.01% 4952
2021
Q3 		$821K Buy
+34,375
New +$840K ﹤0.01% 5248

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bank of America's CRBU Position: Q2 2026 in Review

Bank of America increased its Caribou Biosciences (CRBU) stake by 8.8% in Q2 2026, buying an estimated $225K and bringing the position to 1,410,958 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #4063.

Bank of America first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $14M in Q1 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Bank of America held 1,410,958 shares of Caribou Biosciences worth $2.48M as of Q2 2026.
  • Bank of America bought 113,791 Caribou Biosciences shares in Q2 2026, an estimated $225K.
  • Caribou Biosciences made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4063 holding.
  • Bank of America first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Bank of America's Caribou Biosciences position peaked at $14M in Q1 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.